Inventor profile of:

John Daniel Dobak

City:

La Jolla, California

Country:

United States

Published Applications:

25

Last publication date:

2020-10-01

Top Assignees for applications by John Daniel Dobak

The entities that hold a legal rights for patent applications filed by inventor Dobak John Daniel:

Recent patent applications by Dobak John Daniel

John Daniel Dobak from La Jolla, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-10-01
US20200308657A1
Chemistry; metallurgy

Gene classifiers and uses thereof in skin cancers

#2 | 2020-05-14
US20200149115A1
Chemistry; metallurgy

NON-INVASIVE SKIN-BASED DETECTION METHODS

#3 | 2017-09-21
US20170266137A1
Human necessities

LIPOLYTIC METHODS

#4 | 2017-09-07
US20170252305A1
Human necessities

SODIUM TETRADECYL SULFATE FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE

#5 | 2017-05-18
US20170135923A1
Human necessities

SELECTIVE, LIPOPHILIC, AND LONG-ACTING BETA AGONIST MONOTHERAPEUTIC FORMULATIONS AND METHODS FOR THE COSMETIC TREATMENT OF ADIPOSITY AND CONTOUR BULGING

#6 | 2016-10-06
US20160287611A1
Human necessities

METHODS, COMPOSITIONS, AND FORMULATIONS FOR THE TREATMENT OF THYROID EYE DISEASE

#7 | 2016-09-08
US20160256418A1
Human necessities

METHODS FOR ADMINISTRATION AND FORMULATIONS FOR THE TREATMENT OF REGIONAL ADIPOSE TISSUE

#8 | 2016-02-18
US20160045452A1
Human necessities

Sodium tetradecyl sulfate formulations for treatment of adipose tissue

#9 | 2016-02-18
US20160045416A1
Human necessities

ETHANOLAMINE OLEATE FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE

#10 | 2015-12-17
US20150359760A1
Human necessities

Lipolytic methods

#11 | 2015-11-19
US20150328146A1
Human necessities

Methods for administration and formulations for the treatment of regional adipose tissue

#12 | 2014-10-30
US20140322305A1
Human necessities

Lipolytic methods

#13 | 2012-07-12
US20120178819A1
Human necessities

Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging

#14 | 2012-02-23
US20120046257A1
Human necessities

Methods for administration and formulations for the treatment of regional adipose tissue

#15 | 2012-02-23
US20120046256A1
Human necessities

Lipolytic methods for regional adiposity comprising salmeterol or formoterol

#16 | 2012-01-19
US20120015918A1
Human necessities

Lipolytic methods for regional adiposity

#17 | 2012-01-05
US20120004564A1
Human necessities

Devices and method for accelerometer-based characterization of cardiac synchrony and dyssynchrony

#18 | 2011-09-15
US20110224176A1
Human necessities

Lyophilized Cake Formulations

#19 | 2011-06-02
US20110130373A1
Human necessities

Methods for administration and formulations for the treatment of regional adipose tissue

#20 | 2011-05-05
US20110105446A1
Human necessities

Methods of using lipolytic formulations for regional adipose tissue treatment

#21 | 2010-06-03
US20100137267A1
Human necessities

FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE, CUTANEOUS TISSUE AND DISORDERS, AND MUSCULAR TISSUE

#22 | 2010-06-03
US20100136070A1
Human necessities

METHODS, DEVICES, AND COMPOSITIONS FOR DERMAL FILLING

#23 | 2008-01-24
US20080021336A1
Human necessities

Devices and methods for accelerometer-based characterization of cardiac synchrony and dyssynchrony

#24 | 2007-12-20
US20070293936A1
Human necessities

Systems and methods for creating customized endovascular stents and stent grafts

#25 | 2007-09-20
US20070219596A1
Human necessities

Electric modulation of sympathetic nervous system

InventorID:

952860 ⎘